Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease
NCT05698979
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Buerger Disease
Raynaud Syndrome
Interventions
DRUG:
BOTOX INJECTION
Sponsor
University Hospital, Toulouse